SHINVA MEDICAL INSTRUMENT CO.,LTD. Shinva Medical Instrument Co.,Ltd. Stock
Equities
600587
CNE000001CN3
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.53 CNY | -0.19% |
|
-1.11% | -20.40% |
| Sales 2024 * | 11.07B 1.53B | Sales 2025 * | 13.03B 1.8B | Capitalization | 9.58B 1.32B |
|---|---|---|---|---|---|
| Net income 2024 * | 816M 113M | Net income 2025 * | 1.07B 148M | EV / Sales 2024 * | 0.87 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.74 x |
| P/E ratio 2024 * |
11.7
x | P/E ratio 2025 * |
8.97
x | Employees | 8,209 |
| Yield 2024 * |
1.32% | Yield 2025 * |
1.61% | Free-Float | 65.99% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.19% | ||
| 1 week | -10.74% | ||
| Current month | -10.19% | ||
| 1 month | -10.78% | ||
| 3 months | -15.02% | ||
| 6 months | -13.78% | ||
| Current year | -20.40% |
1 week
20.16
21.55
1 month
20.1624.10
Current year
17.1225.88
1 year
17.1236.95
3 years
13.5336.95
5 years
11.6736.95
10 years
10.7358.63
| Managers | Title | Age | Since |
|---|---|---|---|
Bao Xian Gong
CEO | Chief Executive Officer | 48 | 22-02-22 |
Juan Juan Zhou
DFI | Director of Finance/CFO | 44 | 21-08-12 |
Yu Quan Wang
CHM | Chairman | 56 | 10-11-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yue Yong Wang
BRD | Director/Board Member | 59 | 21-01-26 |
Ai Ling Pan
BRD | Director/Board Member | 59 | 20-05-14 |
Wei Jun Gu
BRD | Director/Board Member | 57 | 20-06-22 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +2.25% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-15 | 20.53 | -0.19% | 7,088,393 |
| 24-04-12 | 20.57 | -1.25% | 4,363,166 |
| 24-04-11 | 20.83 | -1.14% | 5,957,757 |
| 24-04-10 | 21.07 | -1.54% | 9,174,130 |
| 24-04-09 | 21.4 | +3.08% | 9,674,153 |
End-of-day quote Shanghai S.E., April 14, 2024
More quotes
SHINVA MEDICAL INSTRUMENT CO., LTD. is a China-based company principally engaged in the manufacture and distribution of medical equipment. The Company's main products consist of medical sterilization equipment, cleansing and disinfection equipment, sterile supplies, sterilization and supply center project, pharmaceutical sterilization equipment, automatic conveying systems, process control management system, brachytherapy machine and others. The Company is also engaged in the manufacture and sales of pharmacy equipment, as well as the provision of medical services. The Company distributes its products within domestic market and to overseas markets.
Calendar
2024-04-17
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
20.53
CNY
Average target price
31.6
CNY
Spread / Average Target
+53.92%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -20.40% | 1.33B | |
| -1.07% | 189B | |
| -2.61% | 106B | |
| -3.74% | 67.94B | |
| +8.44% | 52.48B | |
| +14.04% | 46.63B | |
| -3.43% | 38.9B | |
| +7.58% | 27.82B | |
| +2.52% | 26.97B | |
| +6.30% | 25.94B |
- Stock Market
- Equities
- 600587 Stock
